Abstract
Background
Primary vitreoretinal lymphoma (PVRL), a subset of primary central nervous system lymphoma (PCNSL), is a high-grade malignant tumor that shows various chorioretinal findings. Optical coherence tomography (OCT) is useful for detecting these lesions, and various abnormalities on OCT images have been reported. The purpose of this report was to investigate retrospectively the OCT manifestations of various disease stages and compare the manifestations of pretreatment, recurrent, and chronic cases.
Methods
We reviewed the medical charts and OCT images of 38 consecutive cases with PVRL. When abnormalities were detected on OCT images, the patients were classified based on the treatment of the primary disease: pretreatment if not treated, recurrent if treated previously, and chronic when chronic changes.
Results
Twenty-six eyes (20 cases) had abnormalities in the post-pole OCT images, i.e., 16 eyes (12 cases) were in the pretreatment group, seven eyes (five cases) were in the recurrent group, and five eyes (five cases) were in the chronic group. Two eyes (two cases) had abnormalities on OCT in the pretreatment and recurrent or chronic stages. The pretreatment and recurrent groups had subretinal or retinal pigment epithelium (RPE) level abnormalities more often than intraretinal changes. Twelve of 16 pretreated eyes and all seven eyes with recurrent disease had subretinal or RPE level abnormalities. One pretreatment case and three recurrent cases had atypical OCT manifestations of intraretinal (round lesions) or epiretinal changes (villous-shaped lesions).
Conclusions
Although pretreatment cases and recurrent cases showed similar OCT abnormalities and the specific changes in the various disease stages were unclarified, collecting OCT data from various disease stages will facilitate detection of typical OCT changes of PVRL and lead to early diagnosis and treatment.
Similar content being viewed by others
References
Gill MK, Jampol LM (2001) Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol 45:463–71
Chan CC, Buggage RR, Nussenblatt RB (2002) Intraocular lymphoma. Curr Opin Ophthalmol 13:411–8
Rajagopal R, Harbour JW (2011) Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 31:435–40
Kimura K, Usui Y, Goto H, Japanese Intraocular Lymphoma Study Group (2012) Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol 56:383–9
Ishida T, Ohno-Matsui K, Kaneko Y, Tobita H, Shimada N et al (2010) Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina 30:23–32
Liang F, Barale PO, Hoang Xuan K, Paques M, Sahel JA (2011) Subretinal lymphomatous infiltration in primary intraocular lymphoma revealed by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 249:1425–7
Liu TY, Ibrahim M, Bittencourt M, Sepah YJ, Do DV et al (2012) Retinal optical coherence tomography manifestations of intraocular lymphoma. J Ophthalmic Inflamm Infect 2:215–8
Forooghian F, Merkur AB, White VA, Shen D, Chan CC (2011) High-definition optical coherence tomography features of primary vitreoretinal lymphoma. Ophthalmic Surg Lasers Imaging 29(42):e97–9
Saleh M, Nikolitch K, Bourcier T, Speeg C, Gaucher D (2012) Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate. Graefes Arch Clin Exp Ophthalmol 250:761–4
Kim E, Kim C, Lee J, Cho Y (2009) A case of primary intraocular lymphoma treated by intravitreal methotrexate. Korean J Ophthalmol 23:210–4
Fardeau C, Lee CP, Merle-Béral H, Cassoux N, Bodaghi B et al (2009) Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol 147:886–94
Casady M, Faia L, Nazemzadeh M, Nussenblatt R, Chan CC et al (2014) Fundus autofluorescence patterns in primary intraocular lymphoma. Retina 34:366–72
Yeh S, Wilson DJ (2010) Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma. Eye (Lond) 24:1625–7
Sou R, Ohguro N, Maeda T, Saishin Y, Tano Y (2008) Treatment of primary intraocular lymphoma with intravitreal methotrexate. Jpn J Ophthalmol 52:167–74
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Funding
No funding was received for this research.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Saito, T., Ohguro, N., Iwahashi, C. et al. Optical coherence tomography manifestations of primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol 254, 2319–2326 (2016). https://doi.org/10.1007/s00417-016-3395-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3395-x